SecuritySCMP / Sucampo Pharmaceuticals, Inc. (864909106)
CEOGreenleaf Peter
IndustryPharmaceutical Preparations
Institutional Owners14
Institutional Shares2,805,584 - 6.02%
Common Shares Outstanding46,636,924 shares (as of 2017-09-30)
Institutional Value$ 38,321,000 USD

Institutional Stock Ownership and Shareholders

Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) has 14 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2,805,584 shares. Largest shareholders include BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., EverPoint Asset Management, LLC, Cornerstone Capital Management Holdings Llc., BlackRock Advisors LLC, BlackRock Investment Management, LLC, MetLife Securities, Inc, Numeric Investors Llc, BlackRock Group LTD, and Capstone Asset Management Co.
Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares		 Current
Shares		 Change
(Percent)		 Prev Value
($1000)		 Current Value
($1000)		 Change
(Percent)
2017-02-10 13F-HR BlackRock Japan Co. Ltd 2,075 162 -92.19 26 2 -92.31
2018-02-14 13F-HR AHL Partners LLP 11,653 0 -100.00 138 0 -100.00
2017-10-31 13F-HR Nine Chapters Capital Management LLC 0 10,800 0 127
2018-02-15 13F-HR Bb&t Investment Services, Inc. 1,659 1,659 0.00 19 30 57.89
2018-04-18 13F-HR/A FNY Partners Fund LP 20,000 0 -100.00 359 0 -100.00
2017-08-04 13F-HR HERNDON CAPITAL MANAGEMENT LLC 458 5
2016-11-14 13F-HR EDMOND DE ROTHSCHILD (SUISSE) S.A. 4,970 0 -100.00 55 0 -100.00
2018-02-14 13F-HR CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. 107,600 114,300 6.23 1,269 2,051 61.62
2018-08-13 13F-HR ADVANTAGE INVESTMENT MANAGEMENT, LLC 311 0 -100.00 6 0 -100.00
2017-11-09 13F-HR TFS CAPITAL LLC 83,694 0 -100.00 879 0 -100.00
2018-05-11 13F-HR HSBC HOLDINGS PLC 443,948 0 -100.00 7,969 0 -100.00
2017-02-10 13F-HR BlackRock Group LTD 20,706 21,651 4.56 255 293 14.90
2018-04-18 13F-HR/A FNY Managed Accounts LLC Put 10 0 -100.00 0 0
2017-07-10 13F-HR CAPSTONE ASSET MANAGEMENT CO 12,100 12,360 2.15 133 130 -2.26
2018-02-14 13F-HR NUMERIC INVESTORS LLC 107,700 0 -100.00 1,271 0 -100.00
2018-08-15 13F-HR GLENMEDE TRUST CO NA 461 0 -100.00 8 0 -100.00
2017-02-14 13F-HR EverPoint Asset Management, LLC 200,000 215,000 7.50 2,462 2,913 18.32
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 726,524 7.48 29 9,844 33,844.83
2018-05-11 13F-HR CITIGROUP INC 235,270 0 -100.00 4,223 0 -100.00
2017-08-14 13F-HR NUMERIC INVESTORS LLC 89,400 47,500 -46.87 983 499 -49.24
2017-10-26 13F-HR Acrospire Investment Management LLC 5,014 0 -100.00 53 0 -100.00
2017-02-10 13F-HR BlackRock Investment Management, LLC 92,311 91,906 -0.44 1,136 1,245 9.60
2017-02-10 13F-HR BlackRock Fund Advisors 1,260,209 1,391,369 10.41 15,513 18,853 21.53
2018-08-17 13F-HR/A NOMURA HOLDINGS INC Call 33,500 0 -100.00 599 0 -100.00
2018-02-12 13F-HR Hutchin Hill Capital, LP 10,300 0 -100.00 122 0 -100.00
2017-02-10 13F-HR BlackRock Advisors LLC 135,146 111,434 -17.55 1,664 1,510 -9.25
2017-01-13 13F-HR MetLife Securities, Inc 0 60,461 0.00 0 819
2018-04-18 13F-HR/A FNY Managed Accounts LLC 1,500 0 -100.00 26 0 -100.00

Related News Stories

Movers and Shakers for Sept. 17

2018-09-17 biospace
Let's take a look at some of the professionals moving to transition the pharma and biotech world this past week. (4-4)

Why Is Mallinckrodt (MNK) Up 14.9% Since Last Earnings Report?

2018-09-06 zacks
A month has gone by since the last earnings report for Mallinckrodt (MNK - Free Report) . Shares have added about 14.9% in that time frame, outperforming the S&P 500. (15-0)

Biotech Movers and Shakers Aug 20

2018-08-20 biospace
This past week’s roundup of Movers and Shakers in the biotech industry started with a surprise. Gilead Sciences' new(ish) chief medical officer was leaving the company six months after taking over the position. (4-0)

Mallinckrodt Is An Attractive Buy Opportunity In 2018

2018-08-17 seekingalpha
The year 2018 is turning out to be transformative for Mallinckrodt (MNK). In Q2 2018, the company reported $632 million worth sales, which was a 5% rise on a year-over-year or YoY basis. Non-GAAP EPS also rose from $1.36 in Q2 2017 to $1.78 in Q2 2018.

Ironwood Pharmaceuticals' Proposed Separation Should Offer A Favorable Outcome For Shareholders

2018-08-17 seekingalpha
Ironwood Pharmaceuticals is a commercial biotechnology company focused on the treatment of gastrointestinal diseases, abdominal pain, and gout. (10-1)

CUSIP: 864909106